Showing results (1261-1270 of 1,482) with videos related to

Sort By:
Pageof 149
Human Psychopharmacology|February 10, 2011
Prolactin as a biomarker for treatment response and tardive dyskinesia in schizophrenia subjects: old thoughts revisited from a genetic perspectiveRenan P Souza, Herbert Y Meltzer, Jeffrey A Lieberman, et al.
Human Psychopharmacology|February 12, 2011
Efficacy of reboxetine in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trialForough Riahi, Mehdi Tehrani-Doost, Zahra Shahrivar, et al.
Human Psychopharmacology|February 12, 2011
The role of nicotine content information in smokers' subjective responses to nicotine and placebo inhalersChristine Darredeau, Sean P Barrett
Human Psychopharmacology|June 17, 2011
Predictors of relapse in a study of duloxetine treatment for patients with generalized anxiety disorderJ Alexander Bodkin, Christer Allgulander, Pierre M Llorca, et al.
Human Psychopharmacology|November 1, 2007
The cognitive effects of modulating the glycine site of the NMDA receptor with high-dose glycine in healthy controlsColin Palmer, Kathryn A Ellis, Barry V O'Neill, et al.
Human Psychopharmacology|June 15, 2007
Hormonal response to buspirone is not impaired in major depressionRicard Navinés, Esther Gómez-Gil, Rocío Martín-Santos, et al.
Human Psychopharmacology|June 21, 2007
Executive function in schizophrenia: what impact do antipsychotics have?Cara O'Grada, Timothy Dinan
Human Psychopharmacology|December 14, 2011
Effects of donepezil on cognitive performance after sleep deprivationChris M Dodds, Edward T Bullmore, Richard N Henson, et al.
Pageof 149